1Barron HV,Randle A,Core JM,et al. Intracranial hemorrhage rate and effect of immediate bata-blocker use in patients with acute mycocardial infarction treated with tissue plaseminogen activator. Am J Cardiol 2000; 85(3) : 294.
2Antman EM, Giugliano RP, Gibason CM, et al. Abciximab faciliates the rate and extent of thrombolysis:results of the thrombolysis in myocaradial infarction [TIMI] 14 trial.Circlulation 1999;199(2) :2720.
3Zahn R,Schiele R,Gitt AK ,et al. primary angioplasty is superior to intravenous thrombobysis in all subgroup of patients: Results of 9906 patients with acute myocardial infraction. Circulation 1999 ; 18(suppl) :359.
4Sakai K, Nadaga W, Kimura T, et al. Direct cornary anigioplasity for acute myocardial infarction in elder patients (> 75 year old). Eurltert J 2000; 21 (supppl):362.
5Maynard C, Every NR. Thrombolysis versus primary angioplasty in older patient with acute myocardial infarction. Drugs Agint, 1999;14(6) :427.
6Lefkorits J, Ivanhare KJ, Califf RM, et al. Effects of platelet glyloprotin Ⅱ a/Ⅲ b receptor blockade by a chimeric monadonal antiboby (abeiximab) on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infraction. Am J Cardiol 1996;77:1047.
7Anonymous. Six-month effects of early treatment with lisinopril and transdermal glyceryl trinitrate singly and together with-drawn six weeks after acute myocardial infraction:the GISSI3 trial. J Am Coil Cardiat 1996;27:337.
